Amylyx Pharmaceuticals EMEA News and Activities

Amylyx Pharmaceuticals EMEA is owned by Amylyx Pharmaceuticals.

Amylyx Pharmaceuticals is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Amylyx Pharmaceuticals is a company listed under the stock ticker AMLX (US).

Amylyx Pharmaceuticals has a direct presence in 2 countries.

View the org chart displaying its 2 main executives

Most searched biographies at Amylyx Pharmaceuticals EMEA

• Bert De Jong, Head and General Manager, Benelux
• Suzanne Bijl, Vice President, Clinical Operations

Popular executive movements at Amylyx Pharmaceuticals

• Baoguang Han has joined the company as Vice President, Biostatistics  (posted on February 19 2026).

Create your alert
to follow the executive moves at Amylyx Pharmaceuticals EMEA.

Amylyx Pharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Amylyx Pharmaceuticals EMEA

Social media about Amylyx Pharmaceuticals EMEA

• Amylyx Pharmaceuticals EMEA on Wikipedia, Google News & Yahoo Finance
• Amylyx Pharmaceuticals EMEA on LinkedIn, X (Twitter) & YouTube